Skip to main content

Table 1 Summary of the serum gastrin concentrations and characteristics of the study population

From: Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies

Patient characteristics Serum gastrin (in ng/L) in acid-suppressant-naïve dogs P Serum gastrin (in ng/L) in acid-suppressant-treated dogs P
Age
  < 6 years 9.9 [9.9–14.9] 0.0770 10.6 [9.9–43.9] 0.5496
  > 6 years 10.8 [9.9–22.8] 18.0 [9.9–34.4]
Sex
 Female 9.9 [9.9–15.3] 0.5102 11.2 [9.9–31.8] 0.4276
 Male 10.0 [9.9–19.4] 13.5 [9.9–44.6]
Breed
 Purebred 10.1 [9.9–19.4] 0.1744 11.4 [9.9–35.0] 0.7206
 Mixed breed 9.9 [9.9–14.4] 15.8 [9.9–46.9]
 German Shepherd (GSD) 12.1 [9.9–15.1] 0.8011 N/A N/A
 Non-GSD 9.9 [9.9–20.0] 11.4 [9.9–35.0]
 Yorkshire Terrier (YT) 11.3 [9.9–14.8] 0.6147 9.9 [9.9–9.9] 0.1202
 Non-YT 10.1 [9.9–19.5] 13.5 [9.9–36.3]
Clinical disease severity (CCECAI score)
 Mild to moderate 9.9 [9.9–14.8] 0.0363 11.2 [9.9–39.8] 0.9911
 Severe to very severe 12.8 [9.9–25.0] 17.6 [9.9–31.2]
Clinical signs
 Vomiting 9.9 [9.9–18.0] 0.6869 10.8 [9.9–33.1] 0.1354
 No vomiting 9.9 [9.9–17.3] 22.8 [10.3–48.2]
 Diarrhea 10.0 [9.9–17.5] 0.5810 24.5 [9.9–12.4] 0.0090
 No diarrhea 9.9 [9.9–16.3] 24.5 [9.9–50.0]
 Weight loss 9.9 [9.9–19.3] 0.6704 19.2 [9.9–44.7] 0.2113
 No weight loss 10.3 [9.9–15.1] 10.7 [9.9–27.1]
 Hypo−/anorexia 10.4 [9.9–23.0] 0.5200 15.2 [9.9–31.8] 0.4983
 No hypo−/anorexia 9.9 [9.9–16.1] 11.4 [9.9–47.5]
  1. P values in boldface and italicized indicate significance at P < 0.05